Maturity-onset Diabetes of the Young Clinical Trial
Official title:
Postprandial Secretion of of Incretin Hormones and Incretin Effect in Patients With Maturity-onset Diabetes of the Young (MODY)
The purpose of this study is to describe the incretin effect and postprandial incretin response in patients with MODY2 and MODY3 and a group of matched healthy subjects. In sulphonyl urea treated subjects the purpose is also to compare the incretin effect with and without treatment. In healthy subjects the purpose is also to investigate the incretin effect under increased levels of endogen incretin hormones.
Comparison of of insulin secretion (AUC) during the experimental days. Furthermore a comparison of GIP, GLP1 and glucagon responses as well as plasma glucose levels. ;
Observational Model: Cohort
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05586594 -
Identifying Maturity-onset Diabetes of the Young in Emirati Patients
|
N/A | |
| Recruiting |
NCT03589092 -
Genetic Causes of Gestational Diabetes in the Emirati Population
|
||
| Completed |
NCT01610934 -
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
|
Phase 2/Phase 3 | |
| Completed |
NCT02556840 -
Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes
|
N/A | |
| Active, not recruiting |
NCT03607604 -
Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE
|